These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 12698850

  • 1. [Long-term administration of tyquanol in the treatment of patients with ischemic heart disease in combination with hyperlipidemia].
    Panchenko VM, Ershov AA, Isaev VA.
    Klin Med (Mosk); 2003; 81(3):40-2. PubMed ID: 12698850
    [Abstract] [Full Text] [Related]

  • 2. [Effects of tycveinol on the lipid transport system and hemostasis and fibrinolysis systems in patients with ischemic heart disease].
    Panchenko VM, Liutova LV, Karabasova MA, Ershov AA, Isaev VA.
    Klin Med (Mosk); 2002; 80(9):54-6. PubMed ID: 12416228
    [Abstract] [Full Text] [Related]

  • 3. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D, Sobieszczańska M, Kopka L, Marciniak W, Zawadzka-Bartczak E, Bak A, Popielewicz-Kautz A, Korzeniowska J, Janczak J, Adamus J.
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [Abstract] [Full Text] [Related]

  • 4. [Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus].
    Panchenko VM, Ershov AA, Isaev VA, ZImovchenko GS, Chernova GI.
    Klin Med (Mosk); 2001 Feb; 79(6):47-9. PubMed ID: 11521381
    [Abstract] [Full Text] [Related]

  • 5. [The effect of long-term Enduracin monotherapy on the clinical and biochemical status of patients with ischemic heart disease].
    Kukharchuk VV, Solov'ev EIu, Malyshev PP, Rozhkova TA, Semenova OA, Aronskaia EE.
    Ter Arkh; 1997 Feb; 69(9):41-5. PubMed ID: 9411824
    [Abstract] [Full Text] [Related]

  • 6. [Comparative efficiency of prolonged diet and drug therapies for hyperlipidemias in patients with ischemic heart disease].
    Mal' GS.
    Klin Med (Mosk); 2004 Feb; 82(5):63-6. PubMed ID: 15230046
    [Abstract] [Full Text] [Related]

  • 7. [Use of biologically active supplement containing omega-3 polyunsaturated fatty acids in patients with type 2 diabetes mellitus].
    Isaev VA, Panchenko VM, Liutova LV, Karabasova MA.
    Vopr Pitan; 2004 Feb; 73(1):16-9. PubMed ID: 15049151
    [Abstract] [Full Text] [Related]

  • 8. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN, Poliakova ED, Olfer'ev AM, Perova NV.
    Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 10. [Influence polyunsaturated fatty acids omega-3 on coagulation and fibrinolysis systems in patients with NIDDM].
    Panchenko VM, Karabasova MA, Liutova LV, Togoev AM, Ershov AA, Chernova GI, Isaev VA.
    Klin Med (Mosk); 2002 Oct; 80(2):40-3. PubMed ID: 11898721
    [Abstract] [Full Text] [Related]

  • 11. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of dyslipidemia.
    Akel MM, Salti I.
    J Med Liban; 2001 Jun; 49(5):274-8. PubMed ID: 12243421
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia].
    Zakharov VN.
    Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342
    [No Abstract] [Full Text] [Related]

  • 16. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
    Koren MJ, Hunninghake DB, ALLIANCE Investigators.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1772-9. PubMed ID: 15519006
    [Abstract] [Full Text] [Related]

  • 17. Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL.
    Winkler K, Weltzien P, Friedrich I, Schmitz H, Nickell HH, Hauck P, Hoffmann MM, Baumstark MW, Wieland H, März W.
    Exp Clin Endocrinol Diabetes; 2004 May 02; 112(5):241-7. PubMed ID: 15146369
    [Abstract] [Full Text] [Related]

  • 18. Drug therapy for hyperlipidemia.
    Franklin FA, Margolis S.
    Cardiovasc Clin; 1984 May 02; 14(3):265-84. PubMed ID: 6722855
    [No Abstract] [Full Text] [Related]

  • 19. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S.
    G Clin Med; 1974 Jan 02; 55(1):27-39. PubMed ID: 4369524
    [No Abstract] [Full Text] [Related]

  • 20. [Lipid peroxidation in patients with ischemic heart disease, hyperlipidemia and/or hypertension while polyunsaturated omega-3 fatty acids of plant and animal origin were in their diet].
    Pogozheva AV, Rozanova IA, Sorokovoi KV, Karagodina ZV, Levachev MM.
    Vopr Pitan; 1997 Jan 02; (4):32-5. PubMed ID: 9412077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.